Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):e60–e71. doi: 10.1097/QAI.0b013e318245d3c1

Table 4.

Risk Factors for Mortality by Cox Proportional Hazards Regression

Variable Reference Group Univariate Multivariate
Hazard Ratio (95% CI) p-value p-value for Variable Hazard Ratio p-value p-value for Variable
Year of ART initiation
 1998–2000 2007–2008 3.21 (2.17 – 4.73) <0.0001 <0.0001 2.17 (0.92 – 5.15) 0.0781 0.1794
 2001–2002 2007–2008 1.27 (0.88 – 1.84 0.1942 0.87 (0.47 – 1.62) 0.6634
 2003–2004 2007–2008 1.54 (1.30 – 1.82) <0.0001 0.94 (0.75 – 1.18) 0.6013
 2005–2006 2007–2008 1.24 (1.04 – 1.47) 0.0151 1.05 (0.85 – 1.31) 0.6240
ART regimen
PI regimen NNRTI 0.88 (0.71 – 1.10) 0.2675 0.3164 N/A N/A N/A
Other regimen NNRTI 1.24 (0.81 – 1.92) 0.3259 N/A N/A N/A
Site
 Barbados Haiti 0.91 (0.72 – 1.14) 0.4209 <0.0001 1.95 (1.37 – 2.76) 0.0002 <0.0001
 Dominican Republic Haiti 1.40 (1.18 – 1.66) <0.0001 1.72 (1.34 – 2.21) <0.0001
 Jamaica Haiti 0.58 (0.42 – 0.80) 0.0010 0.88 (0.52 – 1.47) 0.6183
 Martinique Haiti 0.43 (0.28 – 0.67) 0.0002 1.03 (0.63 – 1.70) 0.8936
 Puerto Rico Haiti 1.59 (1.17 – 2.18) 0.0033 2.25 (1.04 – 4.87) 0.0389
 Trinidad Haiti 0.68 (0.53 – 0.86) 0.0013 0.82 (0.60 – 1.12) 0.2060
Age at ART initiation Unit = 10 years 1.13 (1.07 – 1.20) <0.0001 1.19 (1.11 – 1.28) <0.0001
Gender Female 1.22 (1.08 – 1.38) 0.0014 1.58 (1.33 – 1.87) <0.0001
Intravenous drug use None 1.40 (1.05 – 1.86) 0.0220 1.32 (0.85 – 2.05) 0.2119
Baseline weight Unit = 10 pounds 0.84 (0.82 – 0.87) <0.0001 0.85 (0.82 – 0.89) <0.0001
Baseline hemoglobin Unit = 1 g/dl 0.82 (0.79 – 0.85) <0.0001 0.84 (0.80 – 0.88) <0.0001
Baseline CD4 cell count Unit = 50 cells/ml 0.88 (0.85 – 0.91) <0.0001 0.90 (0.86 – 0.93) <0.0001
TB and ART Co-Treatment No TB 1.84 (1.53 – 2.21) <0.0001 1.58 (1.25 – 2.01) 0.0002